Human CD20 Monoclonal Antibody

Produktübersicht

• Artikelname: Human CD20 Monoclonal Antibody
• Artikelnummer: ABB-YR0130
• Hersteller Artikelnummer: YR0130
• Alternativnummer: ABB-YR0130-1MG,ABB-YR0130-20MG,ABB-YR0130-5MG
• Hersteller: ABclonal
• Kategorie: Antikörper
• Applikation: ELISA, NeA
• Immunogen: Human CD20
• Alternative Synonym: B1, S7, Bp35, CD20, FMC7, CVID5, LEU-16, MS4A1

Produktbeschreibung

Obinutuzumab is an antineoplastic CD20 antibody used to treat untreated chronic lymphocytic leukemia in combination with chlorambucil.In contrast to rituximab, which is a classic type I CD20 antibody, obinutuzumab binds to type II CD20 antibodies. This allows obinutuzumab to have a much higher induction of antibody-dependant cytotoxicity and a higher direct cytotoxic effect than the classic CD20 antibodies.

Produkteigenschaften

• NCBI: 931
• UniProt: P11836
• Reinheit: >95% Determined by SDS-PAGE
• Target-Kategorie: CD20

Anwendungsbeschreibung

• Application Verdünnung: In Vivo Grade Recombinant Human IgG1 Kappa Isotype Control Antibody
• Anwendungsbeschreibung: Cross-Reactivity: <1EU/mg (<0.001EU/µg)Determined by LAL gel clotting assay. ResearchArea: Cancer immunology